Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019

Keyphrases

• Immune-mediated Inflammatory Diseases 100%
• National Incidence 100%
• Global Occurrence 100%
• Global Burden of Disease 2019 100%
• Age-standardized Rate 64%
• Average Annual Percent Change 57%
• Rheumatoid Arthritis 28%
• Asthma 21%
• Atopic Dermatitis 21%
• Psoriasis 21%
• Multiple Sclerosis 21%
• Inflammatory Bowel Disease 21%
• Incident Cases 21%
• Global Burden of Disease Study 14%
• Sichuan 14%
• Incidence Trends 14%
• Disease Case 7%
• High-income 7%
• Age Distribution 7%
• Prevention Management 7%
• North America 7%
• Regional Variation 7%
• High Age 7%
• Increasing Age 7%
• Bill & Melinda Gates Foundation 7%
• Global Level 7%
• Integrative Management Strategy 7%
• Projects Funded 7%
• Research Fund 7%
• Academy of Medical Sciences 7%
• United States of America 7%
• Human Lifespan 7%
• Temporal Trends 7%
• Global Variation 7%

Pharmacology, Toxicology and Pharmaceutical Science

• Inflammatory Disease 100%
• Global Disease Burden 100%
• Rheumatoid Arthritis 28%
• Inflammatory Arthritis 28%
• Psoriasis 21%
• Atopic Dermatitis 21%
• Asthma 21%
• Multiple Sclerosis 21%
• Inflammatory Bowel Disease 21%
• Age Distribution 7%